Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
10.37
-0.37 (-3.45%)
At close: Oct 15, 2025, 4:00 PM EDT
10.40
+0.03 (0.33%)
After-hours: Oct 15, 2025, 7:28 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $711.74 million as of October 15, 2025. Its market cap has increased by 4.17% in one year.
Market Cap
711.74M
Enterprise Value
354.58M
1-Year Change
4.17%
Ranking
Category
Stock Price
$10.37
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $711.74M, a decrease of -60.34%. That is a compound annual growth rate of -17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 711.74M | 65.50% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
| Nov 19, 2020 | 1.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 731.46B |
| Johnson & Johnson | 454.94B |
| AbbVie | 404.56B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.13B |
| Abbott Laboratories | 230.18B |